|Synonyms||NSC-43194; 17α-Methyl-2'H-androsta-2,4-dieno[3,2-c]pyrazol-17β-ol; 17β-Hydroxy-17α-methylandrost-4-eno[3,2-c]-pyrazole|
|Chemical and physical data|
|Molar mass||326.48 g/mol|
|3D model (Jmol)||Interactive image|
|(what is this?)|
Hydroxystenozole (INN), also known as 17α-methylandrost-4-eno[3,2-c]pyrazol-17β-ol, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of testosterone that was described in the literature in 1967 but was never marketed. It is closely related to stanozolol (17α-methyl-5α-androstano[3,2-c]pyrazol-17β-ol), differing from it only in hydrogenation (i.e., double bonds and their placement).
- J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 668. ISBN 978-1-4757-2085-3.